Health Care Technology · Nasdaq
SDGRSchrodinger, Inc.
- Last close
- $29.53 -4.3%
- 52-week range
- $10.95 to $34.00
- Market cap
- $1.86B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own history since 2020
Below its median since 2020 on 1 multiple
Where each multiple sits today inside its own range since 2020, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- n/aNo earnings
- Earnings yield
- -2.7%
- Price / sales
- 6.9x
- Price / book
- 6.2x
- Price / operating cash flow
- n/a
- EV / EBITDA
- n/a
- EV / sales
- 5.5x
- Free cash flow yield
- -6.3%
n/a: Not reported
Profitability
- Gross margin
- 58.5%
- Operating margin
- -49.6%
- Net margin
- -22.0%
- Return on equity
- -19.6%
- Return on capital
- -35.0%
Growth per year
- Revenue, 3 years
- +12.2%
- Revenue, 5 years
- +18.8%
- Revenue, 6 years
- +20.0%
- EPS, 3 years
- n/aNot meaningful (a loss in the window)
Balance sheet
- Cash and investments
- $366M
- Total debt
- n/a
- Net cash
- $366M
- Debt / equity
- n/a
- Current ratio
- 2.75x
n/a: No debt reported
Shares and dividend
- Shares outstanding
- 63.0M
- Share count, 5 years
- +22.4%
- Beta, 1 year
- 1.63
- Dividend yield
- n/a
- Dividend per share, TTM
- n/a
- Payout ratio
- n/a
n/a: No dividend
Every year we have of the business
Last 31 quarters, fiscal 2019 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2019 to 2025.
Where the revenue comes from
Drug Discovery went from 25% to 22% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Software Products and Services | $200M | 78.0% | +11% |
| Drug Discovery | $56.4M | 22.0% | +107% |
Health Care Technology peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc | $48.8B | +16% | 29.9% | 49.4x | 14.1x | 8th percentile |
| DOCS Doximity, Inc. | $5.95B | +6% | 26.3% | 46.4x | 9.0x | 36th percentile |
| WAY Waystar Holding Corp. | $5.39B | +21% | 21.9% | 40.4x | 4.3x | Not enough history |
| SDGR Schrodinger, Inc. | $1.86B | +5% | -49.6% | No earnings | 6.9x | No earnings |
The company
- Sector
- Health Care
- Industry
- Health Care Technology
- Headquarters
- New York, NY
- Fiscal year ends
- December
Around the numbers
What the rest of EdgeStacker knows about SDGR.